Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Obicetrapib placebo
OTHER
2 trials
Sponsors
NewAmsterdam Pharma
Conditions
ASCVD
Dyslipidemias
Familial Hypercholesterolemia
High Cholesterol
Hypercholesterolemia
Phase 2
Study to Evaluate the Effect of Obicetrapib in Combination With Ezetimibe as an Adjunct to HIS Therapy
Completed
NCT05266586
NewAmsterdam Pharma
Dyslipidemias, High Cholesterol, Hypercholesterolemia
Start: 2022-03-09
End: 2022-09-08
Updated: 2024-07-03
Phase 3
Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies
Completed
NCT06005597
NewAmsterdam Pharma
ASCVD, Dyslipidemias, Familial Hypercholesterolemia +2
Start: 2024-03-01
End: 2024-10-16
Updated: 2025-10-08
Related Papers
Fixed-dose combination of obicetrapib and ezetimibe for LDL cholesterol reduction (TANDEM): a phase 3, randomised, double-blind, placebo-controlled trial.
2025-05-07
16 citations